Intranasal oxytocin modulates the salience network in aging.

Aging Functional connectivity Independent component analysis Oxytocin Resting-state fMRI Salience network

Journal

NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515

Informations de publication

Date de publication:
06 2022
Historique:
received: 29 10 2021
revised: 25 02 2022
accepted: 28 02 2022
pubmed: 9 3 2022
medline: 26 4 2022
entrez: 8 3 2022
Statut: ppublish

Résumé

Growing evidence supports a role of the neuropeptide oxytocin in promoting social cognition and prosocial behavior, possibly via modulation of the salience of social information. The effect of intranasal oxytocin administration on the salience network, however, is not well understood, including in the aging brain. To address this research gap, 42 young (22.52 ± 3.02 years; 24 in the oxytocin group) and 43 older (71.12 ± 5.25 years; 21 in the oxytocin group) participants were randomized to either self-administer intranasal oxytocin or placebo prior to resting-state functional imaging. The salience network was identified using independent component analysis (ICA). Independent t-tests showed that individuals in the oxytocin compared to the placebo group had lower within-network resting-state functional connectivity, both for left amygdala (MNI coordinates: x = -18, y = 0, z = -15; corrected p < 0.05) within a more ventral salience network and for right insula (MNI coordinates: x = 39, y = 6, z = -6; corrected p < 0.05) within a more dorsal salience network. Age moderation analysis furthermore demonstrated that the oxytocin-reduced functional connectivity between the ventral salience network and the left amygdala was only present in older participants. These findings suggest a modulatory role of exogenous oxytocin on resting-state functional connectivity within the salience network and support age-differential effects of acute intranasal oxytocin administration on this network.

Identifiants

pubmed: 35259525
pii: S1053-8119(22)00174-4
doi: 10.1016/j.neuroimage.2022.119045
pmc: PMC9450112
mid: NIHMS1830649
pii:
doi:

Substances chimiques

Oxytocin 50-56-6

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

119045

Subventions

Organisme : NIA NIH HHS
ID : R01 AG059809
Pays : United States
Organisme : NIA NIH HHS
ID : R24 AG039350
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000064
Pays : United States

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no competing financial interests.

Références

J Midwifery Womens Health. 2017 Jul;62(4):397-417
pubmed: 28759177
Memory. 2004 Nov;12(6):673-84
pubmed: 15724356
Neuroscience. 2006;138(3):1021-6
pubmed: 16310965
Neuroendocrinology. 2001 Nov;74(5):309-24
pubmed: 11694763
Trends Cogn Sci. 2011 Jul;15(7):301-9
pubmed: 21696997
Curr Opin Neurobiol. 2003 Oct;13(5):620-9
pubmed: 14630228
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7650-4
pubmed: 27325780
Multivariate Behav Res. 2007 Jan-Mar;42(1):185-227
pubmed: 26821081
Handb Clin Neurol. 2013;117:59-77
pubmed: 24095116
Nat Rev Neurosci. 2015 Jan;16(1):55-61
pubmed: 25406711
Psychol Aging. 2015 Dec;30(4):977-86
pubmed: 26389525
Neuroimage. 2004 Jul;22(3):1214-22
pubmed: 15219593
Hum Brain Mapp. 2001 May;13(1):43-53
pubmed: 11284046
Neuroimage. 2017 Nov 15;162:127-137
pubmed: 28877512
Neurobiol Aging. 2014 Oct;35(10):2246-8
pubmed: 24856057
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:105-12
pubmed: 24486563
Psychoneuroendocrinology. 2013 Jul;38(7):962-74
pubmed: 23159011
Eur Neuropsychopharmacol. 2010 Aug;20(8):519-34
pubmed: 20471808
Psychoneuroendocrinology. 2010 Jan;35(1):83-93
pubmed: 19632787
Int J Neuropsychopharmacol. 2014 Oct 31;18(5):
pubmed: 25522395
Neuroimage. 2016 Jan 1;124(Pt A):923-930
pubmed: 26455794
Neuroscience. 2017 Sep 30;360:9-17
pubmed: 28757243
Biol Psychiatry. 2016 Feb 1;79(3):251-7
pubmed: 26210057
Int J Biomed Imaging. 2008;2008:218519
pubmed: 18497865
J Psychopharmacol. 2019 Feb;33(2):250-254
pubmed: 30326770
Psychoneuroendocrinology. 2013 Aug;38(8):1418-25
pubmed: 23352229
Hum Brain Mapp. 2014 Feb;35(2):367-76
pubmed: 22987790
Neuropsychologia. 2015 Jul;73:116-26
pubmed: 25959213
Neural Comput. 1995 Nov;7(6):1129-59
pubmed: 7584893
Brain Connect. 2017 Sep;7(7):401-412
pubmed: 28707959
Neuroimage. 2008 Feb 1;39(3):1227-45
pubmed: 18042495
Brain Imaging Behav. 2020 Dec;14(6):2530-2541
pubmed: 31955321
Cereb Cortex. 2022 Aug 25;:
pubmed: 36005833
Int J Psychophysiol. 2019 Feb;136:22-32
pubmed: 29410310
Neuroimage. 2019 Jan 1;184:781-789
pubmed: 30266264
Gerontology. 2020;66(1):74-84
pubmed: 31390633
Prog Brain Res. 2008;170:337-50
pubmed: 18655894
Front Aging Neurosci. 2018 Aug 06;10:236
pubmed: 30127734
Nat Neurosci. 2013 Jul;16(7):832-7
pubmed: 23799476
Hum Brain Mapp. 2014 Nov;35(11):5606-16
pubmed: 25044711
Trends Cogn Sci. 2005 Oct;9(10):496-502
pubmed: 16154382
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
Annu Rev Psychol. 1995;46:209-35
pubmed: 7872730
Neuroimage. 2006 Feb 15;29(4):1359-67
pubmed: 16260155
Psychoneuroendocrinology. 2018 Oct;96:6-24
pubmed: 29879563
Dialogues Clin Neurosci. 2015 Dec;17(4):463-76
pubmed: 26869847
Hum Brain Mapp. 2014 Apr;35(4):1261-72
pubmed: 23417778
Front Hum Neurosci. 2013 Jun 05;7:200
pubmed: 23761741
Sci Rep. 2013 Dec 06;3:3440
pubmed: 24310737
Neurobiol Aging. 2001 Jul-Aug;22(4):581-94
pubmed: 11445259
Brain Res. 2010 Feb 8;1313:202-14
pubmed: 20004180
IEEE Rev Biomed Eng. 2012;5:60-73
pubmed: 23231989
Endocr Rev. 1992 Feb;13(1):33-65
pubmed: 1348224
Biol Psychiatry. 2007 Nov 15;62(10):1187-90
pubmed: 17617382
Neuropsychopharmacology. 2012 Jul;37(8):1799-807
pubmed: 22510724
J Neurosci. 2010 Apr 7;30(14):4999-5007
pubmed: 20371820
Psychol Aging. 2021 Feb;36(1):10-21
pubmed: 33705182
Eur Psychiatry. 2015 Jun;30(4):542-7
pubmed: 25791179
Int J Neuropsychopharmacol. 2014 Feb;17(2):199-209
pubmed: 24160414
Curr Opin Behav Sci. 2018 Feb;19:7-12
pubmed: 30327789
Neuroimage. 2006 Apr 15;30(3):1050-8
pubmed: 16326117
J Neurosci. 2005 Dec 7;25(49):11489-93
pubmed: 16339042
Brain Connect. 2017 Sep;7(7):454-463
pubmed: 28762756
Int J Neuropsychopharmacol. 2013 Mar;16(2):255-60
pubmed: 22647521
Neuropsychopharmacology. 2016 Mar;41(4):932-9
pubmed: 26272050
Front Psychol. 2022 Jun 23;13:838642
pubmed: 35814062
Endocrinology. 1997 Mar;138(3):1151-8
pubmed: 9048622
Cereb Cortex. 2021 Feb 5;31(3):1848-1860
pubmed: 30535355
Neurosci Biobehav Rev. 2015 Feb;49:182-92
pubmed: 25526824
Emotion. 2012 Oct;12(5):1129-40
pubmed: 21859198
Neuroimage. 2003 Jul;19(3):1233-9
pubmed: 12880848
Neuroimage. 2001 Jul;14(1 Pt 1):21-36
pubmed: 11525331
Trends Cogn Sci. 2011 Feb;15(2):85-93
pubmed: 21167765
Ther Deliv. 2018 Jul;9(7):515-525
pubmed: 29943688
J Cogn Neurosci. 2007 Jun;19(6):935-44
pubmed: 17536964
Eur Arch Psychiatry Clin Neurosci. 2021 Aug;271(5):873-882
pubmed: 32076819
Transl Psychiatry. 2017 Apr 18;7(4):e1099
pubmed: 28418398
Neuroimage. 2010 Apr 15;50(3):1188-93
pubmed: 20045069
J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):349-55
pubmed: 12943721
Front Hum Neurosci. 2012 Oct 11;6:281
pubmed: 23087635
Hum Brain Mapp. 2009 Sep;30(9):2731-45
pubmed: 19072897
Biol Psychiatry. 2007 Sep 1;62(5):429-37
pubmed: 17210143
Brain Connect. 2012;2(3):125-41
pubmed: 22642651
Psychol Aging. 1999 Sep;14(3):427-35
pubmed: 10509697
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9033-4
pubmed: 20448196
Horm Behav. 2009 Jun;56(1):128-32
pubmed: 19344725
Front Endocrinol (Lausanne). 2018 Sep 25;9:572
pubmed: 30356869
Nat Rev Neurosci. 2009 Jan;10(1):59-70
pubmed: 19096369
Front Hum Neurosci. 2013 Aug 28;7:487
pubmed: 24009568
Psychoneuroendocrinology. 2016 Jul;69:50-9
pubmed: 27032063
Neuroscientist. 2011 Feb;17(1):18-24
pubmed: 21071616
Front Syst Neurosci. 2010 May 21;4:21
pubmed: 20577585
Emotion. 2012 Jun;12(3):437-441
pubmed: 22309732
Nature. 2007 May 3;447(7140):83-6
pubmed: 17476267
Perspect Psychol Sci. 2020 Sep;15(5):1228-1242
pubmed: 32633663
Exp Clin Psychopharmacol. 2013 Apr;21(2):85-92
pubmed: 23421352
Neuropsychopharmacology. 2018 Jan;43(2):294-301
pubmed: 28836577
Neuroimage. 2009 Mar;45(1 Suppl):S163-72
pubmed: 19059344
Trends Cogn Sci. 2020 Jul;24(7):515-528
pubmed: 32360118
Neuropsychopharmacology. 2014 Aug;39(9):2061-9
pubmed: 24594871
Psychol Bull. 2017 Oct;143(10):1033-1081
pubmed: 28616997
Neuroimage. 2012 May 1;60(4):1947-58
pubmed: 22361166
Hum Brain Mapp. 2014 Jul;35(7):3446-64
pubmed: 24222384
Psychoneuroendocrinology. 2014 Jan;39:237-248
pubmed: 24157401
Horm Behav. 2018 Mar;99:25-34
pubmed: 29408521
Psychoneuroendocrinology. 2019 Dec;110:104419
pubmed: 31606581
Front Neurosci. 2015 Sep 24;9:335
pubmed: 26441508
Biol Psychiatry. 2011 Aug 1;70(3):291-7
pubmed: 21470595
Sci Rep. 2017 Jul 14;7(1):5483
pubmed: 28710394
Neuropsychopharmacology. 2010 Nov;35(12):2403-13
pubmed: 20720535
Front Endocrinol (Lausanne). 2018 Aug 03;9:403
pubmed: 30123183
Mol Psychiatry. 2012 May;17(5):503-10
pubmed: 21358707
Front Syst Neurosci. 2016 Dec 27;10:104
pubmed: 28082874
Front Psychol. 2015 May 27;6:691
pubmed: 26074845
Neuropsychopharmacology. 2012 Apr;37(5):1257-66
pubmed: 22189289
Neuroimage. 2002 Oct;17(2):657-69
pubmed: 12377141
Psychoneuroendocrinology. 2013 May;38(5):612-25
pubmed: 23265311
Neuropeptides. 2012 Oct;46(5):211-5
pubmed: 22884888
Neuroimage. 2010 Oct 15;53(1):247-56
pubmed: 20621638
PLoS One. 2015 Dec 15;10(12):e0145104
pubmed: 26669935
Curr Behav Neurosci Rep. 2020 Dec;7(4):175-192
pubmed: 33717829
Front Hum Neurosci. 2013 Jul 10;7:343
pubmed: 23847511
Biol Psychol. 2018 May;135:102-111
pubmed: 29548807
Front Aging Neurosci. 2015 Sep 10;7:175
pubmed: 26441637
Physiol Rev. 2018 Jul 1;98(3):1805-1908
pubmed: 29897293
Emotion. 2008 Dec;8(6):781-91
pubmed: 19102589
Front Psychol. 2014 Sep 09;5:1007
pubmed: 25250008
Int J Neuropsychopharmacol. 2018 Oct 1;21(10):918-925
pubmed: 30085122
Psychoneuroendocrinology. 2018 Dec;98:148-152
pubmed: 30149269
Emotion. 2013 Apr;13(2):238-49
pubmed: 23163713
Neurobiol Aging. 2019 Jun;78:42-51
pubmed: 30870779
Neurosci Biobehav Rev. 2017 Jul;78:125-144
pubmed: 28467893
Pharmacol Biochem Behav. 2019 Jan;176:72-82
pubmed: 30521833
Neuroinformatics. 2012 Jul;10(3):269-85
pubmed: 22426994
Psychol Aging. 2014 Mar;29(1):1-15
pubmed: 24660792
Int J Neuropsychopharmacol. 2011 Oct 14;15(7):883-896
pubmed: 21996304
Nat Rev Neurosci. 2011 Aug 19;12(9):524-38
pubmed: 21852800
Hum Brain Mapp. 2014 Oct;35(10):5328-39
pubmed: 24862297

Auteurs

Peiwei Liu (P)

Department of Psychology, University of Florida, Gainesville, FL 32611, USA. Electronic address: peiweiliu@ufl.edu.

Tian Lin (T)

Department of Psychology, University of Florida, Gainesville, FL 32611, USA.

David Feifel (D)

Department of Psychiatry, University of California, San Diego, CA 92093, USA.

Natalie C Ebner (NC)

Department of Psychology, University of Florida, Gainesville, FL 32611, USA; Department of Aging and Geriatric Research, Institute on Aging, University of Florida, Gainesville, FL 32611, USA; Center for Cognitive Aging and Memory, Department of Clinical and Health Psychology, University of Florida, Gainesville, FL 32610-0165, USA; Florida Institute for Cybersecurity Research, University of Florida, Gainesville, FL 32611, USA. Electronic address: natalie.ebner@ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH